Tris Pharma (United States)

912 papers and 41.2k indexed citations i.

About

In recent decades, authors affiliated with Tris Pharma (United States) have published 912 papers, which have received a total of 41.2k indexed citations. Scholars at this organization have produced 152 papers in Pulmonary and Respiratory Medicine, 151 papers in Oncology and 142 papers in Molecular Biology on the topics of Heart Failure Treatment and Management (60 papers), Blood Pressure and Hypertension Studies (50 papers) and Health Systems, Economic Evaluations, Quality of Life (49 papers). Their work is cited by papers focused on Molecular Biology (9.5k citations), Physiology (6.9k citations) and Cardiology and Cardiovascular Medicine (6.7k citations). Authors at Tris Pharma (United States) collaborate with scholars in United States, Switzerland and United Kingdom and have published in prestigious journals including Nature, Cell and Proceedings of the National Academy of Sciences. Some of Tris Pharma (United States)'s most productive authors include Peter J. Elliott, Philip Lambert, Kristijan H. Kahler, Jill C. Milne, Jeffrey Kralstein, Johan Auwerx, John F. Johanson, Zachary Gerhart‐Hines, Marie Lagouge and Pere Puigserver.

In The Last Decade

Fields of papers published by authors at Tris Pharma (United States)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Tris Pharma (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Tris Pharma (United States) at the time of their publication.

Countries citing scholars working at Tris Pharma (United States)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at Tris Pharma (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Tris Pharma (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tris Pharma (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Genopole (France) Breakdown of academic impact, for scholars at Wellcome Centre for Molecular Parasitology Breakdown of academic impact, for scholars at Atkins (United States) Breakdown of academic impact, for scholars at University Memory and Aging Center Breakdown of academic impact, for scholars at École Nationale d'Ingénieurs des Techniques des Industries Agro-Alimentaires Breakdown of academic impact, for scholars at Vancouver Hospital and Health Sciences Centre Breakdown of academic impact, for scholars at Transgene (France) Breakdown of academic impact, for scholars at Genoscope